Dr. Bala has been in academic and private practice Nephrology for 15 years. He has been actively involved in several clinical trials and has served in an advisory role for several start-up and publicly traded biotech companies.

Mr. DeCaro was a general partner at Goldman Sachs (GS) and headed several US and overseas operations and advised senior management on market and reputational risk.

Dr. Pfaffle has over 20 years of experience in healthcare risk management, specializing in drug and device risk evaluation and mitigation. He has served as a healthcare consultant in research and venture funding and has founded or co-founded multiple pharmaceutical companies. Dr. Pfaffle received his MD from New York Medical College and was later appointed to the clinical faculty at both Weill-Cornell Medical College and NYU School of Medicine.

Nick Cassalia is a seasoned professional with over a decade of expertise in healthcare technology. His career has been dedicated to fostering growth through new business strategies, adept customer relationship management, and leading sales teams. His extensive background positions him as a trusted advisor in leveraging technology to revolutionize healthcare delivery.

Ms. Harrison brings 30+ years of experience building and leading health plans and health tech start-ups with strategy, operations, value-based care solutions, and population health management and behavioral health programs. Ellen has extensive expertise in Managed Medicaid and Medicare Advantage. Ellen is a registered nurse and holds a BS in Nursing from Syracuse University and an MBA from the University of Connecticut

Vidya has dual masters in Math and engineering with extensive experience in data science modeling using Bayesian models.

Jill is a strategic leader with extensive experience in innovation of analytics and software solutions that support healthcare organizations in achieving better outcomes for the people they serve. She has worked in large and small health tech organizations and has led development and delivery of solutions for a wide array of commercial and government clients.

Bill Lucia is the former Chairman, President and Chief Executive Officer of HMS, a leading healthcare analytics and technology company. He served as CEO from 2009 to 2021 and was named Chairman of the Board of Directors in July 2015. HMS was acquired by Gainwell Technologies, a portfolio company of Veritas Capital, in April 2021

Michael R. Williams currently serves as the sixth president of the University of North Texas Health Science Center at Fort Worth (HSC) and the fifth Chancellor of the University of North Texas System (UNT System). A Fort Worth native, and first HSC alumnus to serve as President, Dr. Williams practiced anesthesiology and critical care medicine in Texas for more than twenty years.

Venture Partner, Secocha Ventures. Former Medical Director of Value Based Care, Blue Cross Blue Shield of Texas

Former Head of Accident and Health, Swiss Re Former Vice President & Chief Underwriting Officer, Independence Holding Company

Executive Director – Data Science, Kalser Permanente Technolory (one of the nation's largest not-for-profit health plans) Executive Education, Stanford and MIT

Founder and CEO, Windsor Strategies (a leading healthcare actuarial firm) Venture Partner – Payer Services, Falcon Capital Partners Former President, Society of Self- Insurance Institute of America

President, Wilkinson Group Insurance/Stop Loss Founder, Foremost (acquired by Transamerica) Regan career at AiG

Medical Director – Division of Nephrology and Hypertension, UCLA Medical Center Award-winning Associate Professor, UCLA School of Medicine

Nephrology Specialist, Texas Health Resources Fellow of the American Society of Nephrology

Senior Interventional Cardiologist and Quality Committee, Stern Cardiovascular institute, Memphis, TN

Principal and Advisor, Stage Point Capital Former Managing Director – Investment Banking. Oppenheimer & Co. Former Vice President Structured Products and Venture Capital, J. Morgan (LabMorgan)